Your browser doesn't support javascript.
loading
COGNITION: a prospective precision oncology trial for patients with early breast cancer at high risk following neoadjuvant chemotherapy.
Pixberg, C; Zapatka, M; Hlevnjak, M; Benedetto, S; Suppelna, J P; Heil, J; Smetanay, K; Michel, L; Fremd, C; Körber, V; Rübsam, M; Buschhorn, L; Heublein, S; Schäfgen, B; Golatta, M; Gomez, C; von Au, A; Wallwiener, M; Wolf, S; Dikow, N; Schaaf, C; Gutjahr, E; Allgäuer, M; Stenzinger, A; Pfütze, K; Kirsten, R; Hübschmann, D; Sinn, H-P; Jäger, D; Trumpp, A; Schlenk, R; Höfer, T; Thewes, V; Schneeweiss, A; Lichter, P.
Afiliación
  • Pixberg C; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany.
  • Zapatka M; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany.
  • Hlevnjak M; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany; Research Gro
  • Benedetto S; Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Suppelna JP; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany.
  • Heil J; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Smetanay K; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Michel L; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany.
  • Fremd C; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, a partnership betwe
  • Körber V; Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Rübsam M; Research Group Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany.
  • Buschhorn L; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany.
  • Heublein S; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Schäfgen B; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Golatta M; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Gomez C; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • von Au A; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Wallwiener M; Department of Obstetrics and Gynecology, Medical School, University of Heidelberg, Heidelberg, Germany.
  • Wolf S; Genomics and Proteomics Core Facility, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Dikow N; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.
  • Schaaf C; Institute of Human Genetics, Heidelberg University Hospital, Heidelberg, Germany.
  • Gutjahr E; Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Allgäuer M; Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Stenzinger A; Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Pfütze K; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany.
  • Kirsten R; Liquid Biobank, National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany.
  • Hübschmann D; German Cancer Consortium (DKTK), Heidelberg, Germany; Research Group Computational Oncology, Molecular Precision Oncology Program, National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; Heidelberg Institute for S
  • Sinn HP; Department of General Pathology, University Hospital Heidelberg, Heidelberg, Germany.
  • Jäger D; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, University Hospital Heidelberg, Heidelberg, Germany.
  • Trumpp A; Heidelberg Institute for Stem Cell Technology and Experimental Medicine (HI-STEM gGmbH), Heidelberg, Germany; Division of Stem Cells and Cancer, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Schlenk R; Department of Medical Oncology, National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, University Hospital Heidelberg, Heidelberg, Germany; Department of Hematology, Oncology and Rheumatology, Heidelberg University Hospital, Heidelbe
  • Höfer T; Division of Theoretical Systems Biology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Thewes V; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer
  • Schneeweiss A; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; University Hospital Heidelberg, Heidelberg, Germany; German Cancer Research Center (DKFZ), Heidelberg, Germany.
  • Lichter P; National Center for Tumor Diseases (NCT) Heidelberg, a partnership between DKFZ and Heidelberg University Medical Center, Heidelberg, Germany; Division of Molecular Genetics, German Cancer Research Center (DKFZ), Heidelberg, Germany; German Cancer Consortium (DKTK), Heidelberg, Germany. Electronic a
ESMO Open ; 7(6): 100637, 2022 12.
Article en En | MEDLINE | ID: mdl-36423362
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Alemania
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Neoplasias de la Mama Tipo de estudio: Etiology_studies / Risk_factors_studies Límite: Female / Humans Idioma: En Revista: ESMO Open Año: 2022 Tipo del documento: Article País de afiliación: Alemania